Branched-Chain Amino Acid Metabolic Reprogramming Orchestrates Drug Resistance to EGFR Tyrosine Kinase Inhibitors
文献类型:期刊论文
作者 | Wang, Yuetong2,3,4,10; Zhang, Jian2,3,4,10; Sun, Dan2,3,4; Huang, Hsin-Yi2,3,4; Wang, Hua2,3,4; Jin, Yujuan2,3,4; Li, Fuming2,3,4; Zheng, Chao2,3,4; Yang, Liu2,3,4; Jiang, Zhonglin2,10 |
刊名 | CELL REPORTS
![]() |
出版日期 | 2019 |
卷号 | 28期号:2页码:512-+ |
关键词 | capacitance sensor biosensor biochip affinity sensor microfluidics cell detection multidimensional data |
ISSN号 | 2211-1247 |
DOI | 10.1016/j.celrep.2019.06.026 |
文献子类 | Article |
英文摘要 | Drug resistance is a significant hindrance to effective cancer treatment. Although resistance mechanisms of epidermal growth factor receptor (EGFR) mutant cancer cells to lethal EGFR tyrosine kinase inhibitors (TKI) treatment have been investigated intensively, how cancer cells orchestrate adaptive response under sublethal drug challenge remains largely unknown. Here, we find that 2-h sublethal TKI treatment elicits a transient drug-tolerant state in EGFR mutant lung cancer cells. Continuous sublethal treatment reinforces this tolerance and eventually establishes long-term TKI resistance. This adaptive process involves H3K9 demethylation-mediated upregulation of branched-chain amino acid aminotransferase 1 (BCAT1) and subsequent metabolic reprogramming, which promotes TKI resistance through attenuating reactive oxygen species (ROS) accumulation. Combination treatment with TKI- and ROS-inducing reagents overcomes this drug resistance in preclinical mouse models. Clinical information analyses support the correlation of BCAT1 expression with the EGFR TKI response. Our findings reveal the importance of BCAT1-engaged metabolism reprogramming in TKI resistance in lung cancer. |
学科主题 | Cell Biology |
WOS关键词 | CANCER PROGRESSION ; BCAT1 PROMOTES ; GROWTH ; EXPRESSION ; PLASTICITY ; CELLS ; ROS |
语种 | 英语 |
WOS记录号 | WOS:000474580800019 |
出版者 | CELL PRESS |
版本 | 出版稿 |
源URL | [http://202.127.25.144/handle/331004/1297] ![]() |
专题 | 中国科学院上海生命科学研究院营养科学研究所 |
作者单位 | 1.Tongji Univ, Shanghai Pulm Hosp, Sch Med, Shanghai 200433, Peoples R China; 2.Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Cell Biol, Shanghai 200031, Peoples R China; 3.Chinese Acad Sci, CAS Ctr Excellence Mol Cell Sci, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China; 4.Chinese Acad Sci, Innovat Ctr Cell Signaling Network, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China; 5.Peking Univ, Sch Life Sci, Beijing 100871, Peoples R China; 6.Chinese Acad Sci, Inst Hlth Sci, Shanghai Inst Biol Sci, Key Lab Stem Cell Biol, Shanghai 200031, Peoples R China; 7.Xiamen Univ, Innovat Ctr Cell Signaling Network, Sch Life Sci, State Key Lab Cellular Stress Biol, Xiamen 361102, Fujian, Peoples R China; 8.Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; 9.Shanghai Tech Univ, Sch Life Sci & Technol, Shanghai 200120, Peoples R China; 10.Univ Chinese Acad Sci, Beijing 100049, Peoples R China, |
推荐引用方式 GB/T 7714 | Wang, Yuetong,Zhang, Jian,Sun, Dan,et al. Branched-Chain Amino Acid Metabolic Reprogramming Orchestrates Drug Resistance to EGFR Tyrosine Kinase Inhibitors[J]. CELL REPORTS,2019,28(2):512-+. |
APA | Wang, Yuetong.,Zhang, Jian.,Sun, Dan.,Huang, Hsin-Yi.,Wang, Hua.,...&Ji, Hongbin.(2019).Branched-Chain Amino Acid Metabolic Reprogramming Orchestrates Drug Resistance to EGFR Tyrosine Kinase Inhibitors.CELL REPORTS,28(2),512-+. |
MLA | Wang, Yuetong,et al."Branched-Chain Amino Acid Metabolic Reprogramming Orchestrates Drug Resistance to EGFR Tyrosine Kinase Inhibitors".CELL REPORTS 28.2(2019):512-+. |
入库方式: OAI收割
来源:上海营养与健康研究所
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。